Overview

The primary research goal of the Division of Gastroenterology and Hepatology (GIH) is to create scientific discoveries relevant to gastrointestinal and liver diseases and translate those discoveries into clinical practice. The division supports and maintains fundamental, laboratory-based research programs as well as clinical research programs focused on pathophysiology, epidemiology, and the conduct of clinical trials. GIH supports robust career development opportunities for its investigators to ensure future success of its mission of providing the best care to every patient, every day.

In 2007, nearly half of the GIH division’s 25 million dollar research funding came from the National Institutes of Health. Industry partners, non-profit foundations, Mayo Clinic—as well as the generous gifts of our benefactors, patients, and families—all support the research mission. In 2007, the division initiated 55 new human clinical trials and published 427 articles, editorials, and reviews. Research topics include the study of treatment for liver and pancreas disease; investigation of new technologies used in the identification and treatment of inflammatory bowel disease, as well as irritable bowel syndrome and other motility disorders; new generation of endoscopes to perform incision-free procedures; and much more.